Sandra E. Kurtin, RN, MS, AOCN©, ANP-C
Adjunct Clinical Assistant Professor of Nursing
The University of Arizona Cancer Center
Sandra Kurtin graduated from the University of Arizona with a bachelor of science in nursing with high distinction, followed by a master of science in oncology nursing, and post-graduate certification in both geriatric and adult practice. She is currently enrolled in the PhD program at the University of Arizona. Ms. Kurtin, clinical assistant professor of medicine, and adjunct clinical assistant professor of nursing at The University of Arizona Cancer Center, has 30 years of oncology nursing experience, 24 of those in advanced practice, and 19 as a nurse practitioner in oncology. She maintains a busy clinical practice in an NCI-designated Comprehensive Cancer Center with expertise in hematological malignancies, GI malignancies, clinical trials, and symptom management.
Ms. Kurtin is a member of the executive committee for the MDS Foundation. She helped to develop the International Nurse Leadership Board for the MDS Foundation which supports MDS patients, their caregivers, and health care professionals worldwide. She is a member of the International Myeloma Foundation Nurse Leadership Board, currently spearheading an online Survivorship Care Plan application for Myeloma Survivors. She is also a founding board member for the Advanced Practitioner Association for Hematology and Oncology (APSHO), and an active member of the American Society of Hematology (ASH), American Society of Clinical Oncology (ASCO), and the Oncology Nursing Society (ONS). In addition, Ms. Kurtin serves on a number of editorial boards and as a reviewer for peer-reviewed publications relevant to oncology and supportive care. She is widely published in peer reviewed journals, and she lectures nationally and internationally. Her research focus is on caregivers of cancer survivors using a multimedia telehealth intervention aimed at reducing patient and caregiver symptom burden (in particular fatigue), improving patient and caregiver quality of life, and increasing perceived support in cancer survivors.